How genes affect human health and predestine some people to certain medical conditions is the knowledge quest of Newfound Genomics Inc.
Newfound Genomics Inc. is a clinical genomics research company based in Newfoundland that specializes in complex gene disease research & development through novel gene discovery, validation studies and genotyping services.
Using clinical and medical information and analysis, Newfound Genomics has undertaken genetics research to build a better understanding of the relationships between genes, human health and disease. Through this research Newfound Genomics hopes to contribute to an earlier diagnosis of disease, a more accurate prediction of the prognosis of disease and identification of targets that will lead to the development of more effective drugs for the treatment of disease.
By using integrated clinical measurements and genetic information derived from DNA sampling, Newfound Genomics maintains a series of study-specific databases for accurate interpretation and validation.
Business Opportunities
Products and Services
Target Validation of Genes or Critical Regions
Newfound Genomics offers a Target Validation service which includes confirmation of high priority genes and/or regions.
Research
Newfound Genomics offers contract and collaborative research services including project design, ascertainment of cohorts and high throughput genotyping.
Laboratory Services
Newfound Genomics' laboratory services include DNA extraction, storage and high throughput genotyping using state-of-the-art MassARRAY and HuSNP AffyMetrix technology.
Additional Services
While Newfound Genomics' current initiatives focus primarily on human genomics, its capabilities extend beyond this, and include such disciplines as animal, plant and fish research.
Business Objectives
Newfound Genomics is seeking to establish markets to:
Collaborate in novel gene discovery.
Provide service offerings for validation studies.Provide service offerings for genotyping services.Provide laboratory services.
Privacy
Newfound Genomics Inc. is committed to respecting personal privacy, safeguarding confidential information and providing a secure environment for information under its management. Data collection, use and disclosure are guided by the privacy principals of the Canadian Standards Association (CSA), the Canadian Tri Council policy statement on Ethical Conduct for Research Involving Humans.
Investor Relations
For investor information, please contact:
Siobhan Coady
Chief Executive Officer
Newfound Genomics Inc.
187 Lemarchant Road
St. John's, NF
A1C 2H5
Canada
Telephone:
709-753-3900
E-Mail:
siobhan.coady@newfound-genomics.com
Careers
To enquire about a career with Newfound Genomics, please contact:
Hilary Vavasour
Director Corporate Services
Newfound Genomics Inc.
187 Lemarchant Road
St. John's, NF
A1C 2H5
Canada
Telephone:
709-753-3900
E-Mail:
hilary.vavasour@newfound-genomics.com
|